jump to example.com

New dry eye drug aims to treat cause rather than mask symptoms

uva health systemUniversity of Virginia Health System researchers have developed a potential therapeutic treatment for dry eye, with human testing to start in March. The drug differs from other treatments of dry eye in that it aims to treat the cause of dry eye instead of masking the symptoms.

 

About the Drug

The drug, LacripepTM, is a topical eye drop that functions differently from conventional  approaches. Rather than seeking to suppress inflammation – an approach with mixed results – Lacripep aims to eliminate inflammatory triggers by restoring the natural basal tearing mechanism and health of cells in contact with tears. This includes restoration of  the nerves on the cornea of the eye, which signal the brain to produce more tears. It also stabilizes the tear film that in dry eye is very unstable.

Each dose of Lacripep remains in tears rather than being washed away, explained its developer, UVA dry eye research specialist Gordon Laurie, PhD, of the School of Medicine’s Department of Cell Biology.

“Most ophthalmic drugs are washed away right away, but that’s not the case here. Lacripep is still in the tears 24 hours later, because it goes into the lipid layer and apparently comes out of the lipid layer slowly to treat the eye,” Laurie said.

 

Current Treatments

Dry eye affects between 5 percent and 9 percent of the population, with that number increasing to around 35 percent in older women. The condition can occur due to hormonal imbalances, malfunctioning aqueous tear production or lipid production, and general inflammation of the eye. Current treatments aim to suppress the pain and damage caused by dry eye, including steroids to control inflammation, antibiotics and artificial tears. These are temporary fixes that do not treat what may be the root cause of the disease – a shortage of the tear protein lacritin – and often lead to frustration and pain for people with the condition. Lacripep is a short synthetic fragment of lacritin. If successful, Lacripep would be the first drug to treat that cause of dry eye.

“We think that dry-eye disease may be much simpler than people have thought in the past, sort of like insulin and type I diabetes,” Laurie said. “With lacritin deficient in dry-eye tears, topical Lacripep is a replacement therapy, which will probably not cure the disease. You would still have to keep treating your eyes, but maybe just once a day.”

 

The Study

The small-scale clinical trial, called a Phase I/II clinical trial, will begin in March at 25 clinical sites nationwide. More than 200 patients will be recruited. The patients will use two different dosages of Lacripep or placebo three times daily for four weeks. If safe and effective, testing will then expand to a much larger Phase III trial. Should that prove successful, the Food and Drug Administration could consider making the drug available as a treatment.

Laurie’s Charlottesville company, TearSolutions Inc., has contracted with Lexitas Pharma Services in Durham, N.C., to run the clinical trial. The first trial will accept only patients with Sjögren’s syndrome dry eye.

UVA also has a stake in the drug’s success. TearSolutions worked with the UVA Licensing and Ventures Group to license the patents exclusively for its company. This means UVA will benefit from royalties on any future sales of the drug.

Discussion
 
Top News
 
a

AAA: Gas prices holding steady

Gas prices across the Mid-Atlantic region appear to be treading water as the consistent dip in prices seen for the past few weeks has begun to stall.

Street Knowledge with Chris Graham: Previewing UVA-UNC

Chris Graham previews the matchup between #14 UVA and #10 UNC in ACC Saturday Night Hoops.

Poll: Kaine with big leads in early look at 2018 U.S. Senate race

Sen. Tim Kaine has big leads on two possible big-name Republican challengers in an early, early look at his 2018 re-election race.

Staunton man arrested in drug sting

A Staunton man is behind bars after being arrested Thursday on multiple drug charges following an investigation by federal, state and local law enforcement.

David Swanson: Understanding Robert E. Lee supporters

A message to those who consider it disgraceful to have a giant statue of Robert E. Lee in the middle of Charlottesville.

Poll: Perriello, Northam tied, both lead GOP contenders for governor

Tom Perriello and Ralph Northam are tied in the race for the Democratic Party nomination for governor.

Report: About a third of Virginia farm workers are immigrants

New data emphasizes the contributions of immigrants to Virginia agriculture and the need for immigration reform.

Reality starting to sink in: Ceiling for this UVA team not as high as we thought

I feel like I just watched an overmatched UVA team lose a game in I don’t know how long.

#12 Duke rallies, tops #14 UVA, 65-55

#12 Duke beat #14 UVA at its own game, holding the Cavs to a season-low in a 65-55 win Wednesday night.

Waynesboro Salvation Army to close thrift store

The Waynesboro Salvation Army announced that its Family Thrift Store on Arch Avenue will close March 31.

 
Recent News
 

Your One-Stop Media Shop

Augusta Free Press LLC provides clients in the Shenandoah Valley and Central Virginia and beyond with marketing and PR solutions including web design, magazine/brochure, TV/radio, social media and overall marketing campaign design and implementation.
  • Web Design

    You want a new website, but don’t have the first clue as to how to build one. That’s our job. We take care of all facets of web design – visual design, layout design and content development. Get your business online for as little as $1,299.
    Learn more about AFP Web Design services.
  • Graphic Design

    The staff at Augusta Free Press Publishing has been recognized by the Virginia Press Association for excellence in layout and design. Whether you need a fresh business card design, rack card, ad, flyer or full magazine design, we can help with all your graphic-design needs.
    Learn more about AFP Graphic Design services.
  • Marketing

    Augusta Free Press manages advertising campaigns for small- and medium-sized businesses across Virginia. You don’t need to hire a full-time marketing coordinator. Bring the experience of the Augusta Free Press team to work for you – for a fraction of the cost.
    Learn more about AFP Marketing services.